SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-121036
Filing Date
2018-04-18
Accepted
2018-04-18 16:06:03
Documents
7
Effectiveness Date
2018-04-18

Document Format Files

Seq Description Document Type Size
1 DEFA14A d513033ddefa14a.htm DEFA14A 35602
2 GRAPHIC g513033g05e15.jpg GRAPHIC 23408
3 GRAPHIC g513033g16q56.jpg GRAPHIC 13701
4 GRAPHIC g513033g18r02.jpg GRAPHIC 8555
5 GRAPHIC g513033g62d05.jpg GRAPHIC 24728
6 GRAPHIC g513033g76c99.jpg GRAPHIC 32714
7 GRAPHIC g513033g87n84.jpg GRAPHIC 13084
  Complete submission text file 0001193125-18-121036.txt   197185
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS INC (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36014 | Film No.: 18761273
SIC: 2834 Pharmaceutical Preparations